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Cinnamaldehyde (1) is a pharmacologically active ingredient isolated from cassia twig
(Ramulus Cinnamomi), which is commonly used in herbal remedies to treat
fever-related diseases. Both TRPV1 and TRPM8 ion channel proteins are abundantly
expressed in sensory neurons, and are assumed to act as a thermosensor, with the
former mediating the feeling of warmth and the latter the feeling of cold in the body.
Both of them have recently been reported to be involved in thermoregulation.
The purpose of this paper is to further uncover the antipyretic mechanisms of 1 by
investigating its effects on the mRNA expression levels and functions of both TRPV1
and TRPM8. The results showed that 1 could up-regulate the mRNA expression levels
of TRPV1 at both 37 and 398C, and its calcium-mediating function was significantly
increased at 398C, all of which could not be blocked by pretreatment of the neuronal
cells with ruthenium red, a general transient receptor potential (TRP) blocker,
indicating that the action of 1 was achieved through a non-TRPA1 channel pathway.
In conclusion, the findings in our in vitro studies might account for part of the
peripheral molecular mechanisms for the antipyretic action of 1.
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1. Introduction
Guizhi-Tang (decoction of cassia twig) is
one of the most effective herbal formulae
in the classical works of Shang-han-lun
(Treatise on Exogenous Febrile Disease),
and has been widely used to treat
influenza, common cold, and other pyretic
conditions. Cinnamaldehyde (1) is one of
the principal ingredients isolated from
Guizhi-Tang, which was previously found
to relieve fever and pain [1], as well as
to inhibit the growth of various
organisms [2].
Recently, it has been found to inhibit
cyclooxygenase (COX)-2 activity with an
IC50 value of 245mM in vitro and to induce
endothelium-dependent and independent
vasorelaxant action on isolated rat aorta
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[3,4]. Moreover, 1 has been reported to
have anti-oxidant effects, evoke significant
spontaneous pain, induce heat and mech-
anical hyperalgesia, and cause cold
hypoalgesia by application to the skin in
study participants [5]. In addition, a
previous study in our laboratory showed
that 1 reduced the TRPV4 expression in
b.End3 cells, which indicated this might be
the antipyretic mechanism of 1 through a
central temperature regulation center [6].
However, the putative peripheral antipyre-
tic and hyperalgesic mechanisms induced
by 1 as well as the correlations between
them remain obscure.
Accumulating evidence indicates that
ion channels of the transient receptor
potential (TRP) family are evolutionarily
conserved participants in the peripheral
mechanisms by which we sense hot and
cold temperatures, and that these channels
may also contribute, directly or indirectly,
to thermoregulation [7]. Among them,
several lines of evidence have shown that
the capsaicin-sensitive vanilloid receptor
(TRPV1), which can be activated by
temperature over 428C or capsaicin, in
the detection of noxious stimuli [8], as
well as TRPM8, a non-selective, calcium-
permeable cation channel of the TRP
family, which can be activated by cooling
and menthol, might be involved in the
thermoregulation through peripheral-sen-
sing mechanism [9].
Thus, in the present study, we inves-
tigated the effects of 1 on the mRNA
expression levels of both TRPV1 and
TRPM8 as well as the functions of these
channel proteins as mediators of calcium
entrance into the cytoplasm of primary
dorsal root ganglion (DRG) neurons
in vitro in order to further explore the
antipyretic mechanisms of 1. In view of
the fact that 1 is a known TRPA1 channel
activator, its influence on the expression
and functions of the TRPV1 and TRPM8
might be related to the mediation of the
TRPA1 channel. So, in this experiment,
ruthenium red (RR), a commonly used
non-selective TRPA1 blocker, was under-
taken to verify this hypothesis.
2. Results and discussion
2.1 Cytotoxic effect of cinnamaldehyde
on the primary DRG neurons
To test whether cinnamaldehyde (1)
treatment has cytotoxic effects, viability
assays of the primary DRG neurons were
performed to determine the optimal
concentrations for 1. The primary
DRG neurons were incubated for 24 h
with various concentrations of 1, followed
by viability assay. The results demon-
strated that viabilities of the cells for
40, 80, 160, 300, and 400mM of 1
were 101.86 ^ 10.90, 93.99 ^ 9.16,
98.36 ^ 8.90, 91.80 ^ 9.47, and
90.52 ^ 9.33 (% control), respectively.
No significant differences were found for
any group compared with the control
group ( p . 0.05 vs. control), indicating
that 1 below 400mM had no cytotoxic
effects on the cells. As a consequence
of these studies, all subsequent incubations
with 1 were performed below 400mM.
2.2 Effect of the temperature on the
viability of the primary DRG neurons
Viability assays of the primary DRG
neurons were performed to make sure
that the temperature range and duration
we selected for the subsequent exper-
iments did not induce neurotoxicity.
The primary DRG neurons were incu-
bated for 12 h at 37 or 398C, followed by
viability assays. The results demonstrated
that the viability of the cells at 398C was
98.50 ^ 10.41 (% of control) and no
significant difference was shown com-
pared with the control group at 378C
( p . 0.05 vs. control), indicating that no
cytotoxic action was exerted by the
higher temperature after the 12 h incu-
bation. As a result of these studies, all
subsequent incubations with cinnamalde-
hyde were performed under those tem-
perature conditions.



































2.3 Effects of cinnamaldehyde on the
levels of TRPV1 and TRPM8 mRNA
expression under the temperature
condition of 378C
Detection of the expression of TRPV1 and
TRPM8 mRNA was performed using real-
time PCR. Melting curve analysis con-
firmed that there was no primer dimer in
PCR products. For each of the primer sets,
the specificity and efficacy of cDNA’s
amplification for both the target genes and
the internal control were visualized and
evaluated. The results indicated that no
non-specific amplification was visualized
and the amplification efficacies of the
cDNAs were relatively close and suitable
for analysis by the method of 22DDCT
(Figures 1 and 2).
In the present study, it is demonstrated
that the TRPV1 mRNA expression is
significantly up-regulated after the action
of 60 or 30mM cinnamaldehyde (1) for
both RR-free (170.59 ^ 35.29,
126.43 ^ 31.37 (% of control); p , 0.01,
p , 0.05 vs. control, respectively) and
plus RR (161.54 ^ 31.73, 126.92 ^ 32.69
(% of control); p , 0.01, p , 0.05 vs.
control, respectively) conditions for 12 h at
378C (Figure 3), while the effect of 1 on
the TRPM8 mRNA expression is not
significantly different (88.12 ^ 18.75,
90.10 ^ 19.80, 95.05 ^ 22.92 (% of con-
trol); p . 0.05 for any groups vs. control).
No significant difference was shown
between the RR-free and plus RR groups
of a similar concentration of 1 ( p . 0.05
for any groups) and the significant effects
of 1 on the TRPV1 mRNA expression
were not blocked by pre-incubation of the
neurons with RR, indicating that 1 might
exert its action on TRPV1 by additional
cellular mechanisms other than the TRPA1
channel (Figure 3).
2.4 Effects of cinnamaldehyde on the
levels of TRPV1 and TRPM8 mRNA
expression under the temperature
condition of 398C
From the experimental results, it could
be identified that the TRPV1 mRNA
expression was markedly up-regulated
after cinnamaldehyde 60, 30 or
15 mM stimulation for both RR-
free (251.49 ^ 40.59, 180.20 ^ 35.64,
125.74 ^ 28.71 (% of control); p , 0.01,
p , 0.01, p , 0.05 vs. control, respect-
ively) and plus RR (233.33 ^ 36.27,
172.55 ^ 30.39, 126.47 ^ 27.45 (% of
control); p , 0.01, p , 0.01, p , 0.05
vs. control, respectively) conditions
for 12 h at 398C in a dose-dependent
Figure 1. Melting curves of the amplification
products from TRPV1, TRPM8, and GAPDH.
RFU, relative fluorescence unit.
Figure 2. Amplification curves for the cDNAs
of TRPV1, TRPM8, and GAPDH.



































manner (Figure 4), while the effect
of cinnamaldehyde on the TRPM8
mRNA expression was not significantly
different (96.32 ^ 19.83, 98.10 ^ 19.05,
94.88 ^ 20.26 (% of control); p . 0.05
for any groups vs. control). As demon-
strated under the temperature condition of
378C, the significant effect of cinnamalde-
hyde on the TRPV1 mRNA expression
was not blocked by pretreatment of the
neurons with RR (Figure 4).
2.5 Effects on the functions of TRPV1
and TRPM8 ion channel proteins in DRG
neurons pretreated with cinnamaldehyde
under the temperature condition of 378C
The experimental results revealed that
most of the small-sized DRG neurons
(around 70% of the total neurons)
exhibited a significant elevation of intra-
cellular Ca2þ induced by 5mM capsaicin
in the presence of extracellular 1.25mM
calcium. This is consistent with previous
reports [10]. It was demonstrated that the
concentration of intracellular calcium
increased upon addition of capsaicin, and
reached the peak value at about 120 s, and
then decreased toward the resting level
gradually (Figure 5). The elevated ampli-
tude of intracellular calcium by capsaicin
could not be changed markedly by
preincubation of the DRG neurons with
any of the three doses of cinnamaldehyde
(105.32 ^ 20.66, 101.60 ^ 18.71,
104.08 ^ 19.43 (% of control); p . 0.05
for any groups vs. control), indicating that
cinnamaldehyde might not change the
calcium-mediating function of TRPV1
receptor channel protein under this tem-
perature condition.
For the imaging experiment of
TRPM8, the basal temperature of the
bath solution for which the cells were
maintained was 268C. Higher basal tem-
perature was not necessary for this study
because TRPM8 receptors are not signifi-
cantly activated at temperature .258C
when the cells are near resting membrane
Figure 3. Effects of cinnamaldehyde on the levels of the TRPV1 mRNA expression under the
temperature condition of 378C. TRPV1 mRNA expression levels of TRPV1 in the presence of 60mM
cinnamaldehyde, 30mM cinnamaldehyde, 15mM cinnamaldehyde, or 10mM RR either alone or in
different combinations were measured using the method of relative quantitative real-time RT-PCR
(n ¼ 10). The results represent three independent experiments. ##p , 0.01, #p , 0.05 vs. normal
control; **p , 0.01, *p , 0.05 vs. RR alone. Cin, cinnamaldehyde; RR, ruthenium red.



































Figure 5. Intracellular changes of fluorescent intensity evoked by TRPV1 and TRPM8 agonists in
DRG neurons. (a),(c) Loaded DRG neurons with Ca2þ indicator Fluo-4 AM dye. (b) Capsaicin
(5mM)-induced increase of intracellular fluorescent intensity of DRG neurons. (d) Menthol
(100mM)-induced increase of intracellular fluorescent intensity of DRG neurons. (e) Capsaicin
(5mM)-induced intracellular changes of fluorescent intensity in DRG neurons. (f) Menthol
(100mM)-induced intracellular changes of fluorescent intensity in DRG neurons. Cap, capsaicin;
Men, menthol.
Figure 4. Effects of cinnamaldehyde on the levels of the TRPV1 mRNA expression under the
temperature condition of 398C. TRPV1 mRNA expression levels of TRPV1 in the presence of 60mM
cinnamaldehyde, 30mM cinnamaldehyde, 15mM cinnamaldehyde, or 10mM RR either alone or in
different combinations were measured using the method of relative quantitative real-time RT-PCR
(n ¼ 10). The results represent three independent experiments. ##p , 0.01, #p , 0.05 vs. normal
control; **p , 0.01, *p , 0.05 vs. RR alone. Cin, cinnamaldehyde; RR, ruthenium red.



































potentials [11]. Of the DRG neurons
tested, nearly 10% of them demonstrated
increased Fluo-4 fluorescence intensity of
intracellular Ca2þ induced by menthol
(Figure 5). It was identified that the
elevated amplitude of intracellular calcium
by menthol could not be changed
markedly by incubation of the DRG
neurons with cinnamaldehyde of various
doses (98.60 ^ 17.84, 97.25 ^ 19.13,
102.24 ^ 21.03 (% of control); p . 0.05
for any groups vs. control), indicating that
cinnamaldehyde might not change the
calcium-mediating function of TRPM8
receptor channel protein at 378C.
2.6 Effects on the functions of TRPV1
and TRPM8 ion channel proteins in DRG
neurons pretreated with cinnamaldehyde
under the temperature condition of 398C
The elevated amplitude of intracellular
calcium evoked by capsaicin could be
promoted markedly by the pretreatment of
the DRG neurons with 60 or 30mM
cinnamaldehyde (1) for both RR-free
(126.79 ^ 21.43, 119.64 ^ 19.64 (% of
control); p , 0.01, p , 0.05 vs.
control, respectively) and plus RR
(129.02 ^ 23.67, 118.75 ^ 21.43 (% of
control); p , 0.01, p , 0.05 vs. control,
respectively) conditions for 12 h at 398C.
No significant difference between the RR-
free and plus RR groups of the similar 1
concentration was shown ( p . 0.05 for
any groups), and the significant increases
of the calcium-mediating function of the
TRPV1 channel after the action of 60 or
30mM of 1 could not be masked by the
preincubation of the DRG neurons with
RR ( p , 0.01 or p , 0.05 vs. RR alone,
respectively), indicating that the up-
regulated function of TRPV1 induced by
1 was probably not achieved through the
TRPA1 pathway (Figure 6). For the
imaging experiment of TRPM8, it was
shown that the elevated amplitude of
intracellular calcium induced by menthol
could not be changed markedly by
the pretreatment of the DRG neurons
with 1 of various doses (96.17 ^ 18.20,
93.44 ^ 19.84, 98.05 ^ 21.46 (% of con-
trol); p . 0.05 for any groups vs. control),
suggesting that 1 might not change the
Figure 6. Effects of cinnamaldehyde on the functions of TRPV1 ion channel protein under the
temperature condition of 398C. The functions of TRPV1 in the presence of 60mM cinnamaldehyde,
30mM cinnamaldehyde, 15mM cinnamaldehyde, or 10mM RR either alone or in different
combinations were measured using the method of confocal microscopy (n ¼ 10). The results
represent three independent experiments. ##p , 0.01, #p , 0.05 vs. normal control; **p , 0.01,
*p , 0.05 vs. RR alone. Cin, cinnamaldehyde; RR, ruthenium red.



































calcium-mediating function of TRPV1
receptor channel protein.
2.7 Discussion
Over the past decade, considerable evi-
dence supporting a role for TRP channels
in temperature sensation has emerged from
a number of mammalian and non-mam-
malian systems. These data can be most
readily explained by the existence of
multiple thermally sensitive TRP chan-
nels, each contributing to temperature
sensation over a different range and in
different anatomical locations. TRPV1-4s
are activated when the temperature is
higher than thresholds while TRPM8 and
TRPA1 are activated when the tempera-
ture is lower than thresholds [12].
Among these recently cloned and
characterized ‘thermoTRP’ channels, the
following facts support the involvement of
tonic TRPV1 activation in body thermo-
regulation: (1) agonists of TRPV1 cause
hypothermia in rodents and humans [13];
(2) there is an absence of agonist-induced
hypothermia in TRPV1 knock-out mice
[14]; (3) antagonists of TRPV1 represent-
ing multiple different chemotypes cause
hyperthermia in rats [10]; (4) there is a
correlation of antagonism of TRPV1
activation by antagonists with hyperther-
mia in dogs and monkeys [15]; (5) TRPV1
knock-out mice show some impairment in
thermoregulation [16]; and (6) there is an
absence of antagonist-induced hyperther-
mia in knock-out mice [17].
TRPM8 has recently been identified as
a distant relative of TRPV1 (the receptors
show only 20% identity in protein
sequence) by a bioinformatics approach
[17]. Recently, several lines of evidence
have indicated a potential functional role
of TRPM8 in thermoregulation as a
menthol- and cold-sensitive ion channel
in sensory neurons for the detection of cold
temperature of ,258C. In contrast to
TRPV1, agonists of TRPM8 evoke
hyperthermia in rodents [9,18]. Additional
support for the participation of TRPM8 in
physiological cold transduction comes
from the observation that its expression is
confined largely to a subpopulation of
small-diameter peripheral sensory neurons
that under normal conditions are distinct
from those that express TRPV1 [9,19,20].
For a specific gene, from transcription
start to translation, there are several
critical processes and steps that are
involved which are under refined physio-
logical regulation and strict control. In the
present study, we examined the effects of
cinnamaldehyde (1) on TRPV1 and
TRPM8 receptor potential ion channels
both at the transcription levels of gene
expression and on the functional activities
of the post-translational proteins. The
levels of the TRPV1 and TRPM8 mRNA
expression were detected by real-time
quantity PCR with SYBR green dye, and
significantly different mRNA expression
levels in various groups were observed
using the relative quantitative method
of 22DDCT, which is especially suitable
for the detection of target genes with
relatively short PCR products of equal
amplification efficiency as those in our
experiments. For the pair of primer sets,
non-specific amplification was not visual-
ized after electrophoresis and ethidium
bromide staining of agarose gels; however,
amplification efficiencies of TRPV1 and
TRPM8 mRNA in the various groups were
also assayed. The results showed that real-
time PCR conditions used in the study
were suitable for the detection of the
TRPV1 and TRPM8 mRNA expression in
the DRG neuronal cells as well as for the
analyses of relative expression levels of
various groups.
By using camptothecine (CPT) as an
agent to eliminate the non-neuronal cells,
we acquired primary DRG cultures with
high purity and viability. On this basis, we
first studied the effects of 1 on the
expression of TRPV1 and TRPM8
mRNA in vitro. It was demonstrated that
the level of the TRPV1 mRNA expression



































in the neurons of the primary DRG
cultures was significantly increased after
being incubated with 1 for 12 h under the
temperature condition of 378C. Interest-
ingly, when the temperature at which DRG
neurons incubated with 1 is increased to
398C, a simulated in vitro pathological
condition for fever, the up-regulated
TRPV1 mRNA expression levels in the
DRG neurons induced by 1 seemed more
significant with all of the three doses
markedly higher than the control in a dose-
dependent manner. Since TRPV1 and
TRPM8 are non-selective cation channels
with preference for Ca2þ ions, measure-
ment of [Ca2þ]i evoked by their corre-
sponding agonists can be used to assess the
channel’s activity. With capsaicin and
menthol as agonists of TRPV1 and
TRPM8 channels, respectively, as well as
Fluo-4-AM as a calcium indicator, the
increased amplitude of intracellular
[Ca2þ]i induced by capsaicin or menthol
was measured by confocal microscopy.
Of note, there also exists a bimodal
modulation of TRPA1 gating by menthol.
At low micromolar concentrations,
menthol leads to an overall increase of
TRPA1 current [21]. That is the reason
why in this experiment we set the
application concentration of menthol to
100mM, at which menthol induces a rapid
channel block of TRPA1 rather than an
agonizing action. It follows that the
increased calcium provoked by menthol
in the present study could be considered to
be achieved through the opening of just
TRPM8 channels. The calcium measure-
ment results showed that the intracellular
fluorescence intensity induced by capsai-
cin in the DRG neurons was not signifi-
cantly different between the three 1 groups
of different doses and the control group
under the temperature condition of 378C,
which is not consistent with the results for
the mRNA expression level under the
same temperature condition. This appar-
ently paradoxical phenomenon for the
inconsistence of changes between the
mRNA expression level and calcium-
mediating function of the TRPV1 channel
might be explained by our speculation that
the up-regulated TRPV1 mRNA
expression level could be reversed through
one or several post-transcriptional path-
ways though the specific mechanisms still
need to be further researched. In contrast,
after being pretreated with 1 for 12 h under
the temperature condition of 398C, the
intracellular fluorescence intensity
induced by capsaicin in the DRG neurons
was significantly higher than that in the
control group, which is fundamentally in
agreement with the results acquired in the
PCR experiments under the same tem-
perature condition. These results seemed
to support the notion that a higher body
temperature than the normal one such as
fever might be the preferred settings for 1
to exert its antipyretic action.
On the premise that the TRPA1
channel could be activated by 1, concerns
have been raised with respect to the
possibility that the up-regulated
expression and function of TRPV1 by 1
were accomplished through the pathway of
TRPA1. Thus, RR, a known non-selective
antagonist of TRPA1, was employed in
this experiment to detect whether TRPA1
was involved in the 1-induced gene
expression and functional changes for
TRPV1. From the experimental results, it
could be identified that the significant
effect of 1 on the TRPV1 mRNA
expression and function was not blocked
by the pretreatment of the neurons with
RR, indicating that the effect produced by
1 is mediated through the non-TRPA1
channel pathway.
As reported in the literature, the
TRPV1 expressed in thermal sensory
neurons innervating the body surface
takes part in body thermoregulation and
pain perception through transducing the
changes in thermal energy into an
electrical signal by opening its channels
to temperature of .428C [22,23]. How-
ever, this threshold temperature would be



































lowered by some endogenous or exogen-
ous inflammatory mediators to some
extent in acute or chronic inflammatory
states [23]. Thus, combined with the
results found in our experiments, we
have the reason to postulate that the up-
regulation of the TRPV1 expression and
function might compose an important
molecular basis for promoting the sensi-
tivity of the TRPV1 channel to higher
temperatures as well as for hypersensitiv-
ity to pain. As a result, some temperature-
lowering mechanisms might be initiated
through integration of temperature infor-
mation collected from TRPV1 channels by
the central nervous system, which, in turn,
contributes to the relief of fever under
pathological conditions.
In conclusion, our data indicate that the
expression levels and functions of TRPV1
in the DRG neurons could be up-regulated
by 1 through the non-TRPA1 channel
pathway, which may be one of the main
molecular antipyretic mechanisms of 1 as
well as an important reason for hyper-
algesia evoked by 1. These results also
suggest that Guizhi-Tang’s antipyretic
action, especially the peripheral, might
be partially attributed to 1. It is important
to note, however, that the analyses in the
present study were all based on in vitro
results. Thus, other in vivo studies using
more precise techniques and strategies are
still necessary to further clarify the patho-
physiological role of TRPV1 in thermo-
regulation as well as to elucidate the
involvement of 1-induced up-regulation of
TRPV1 in thermoregulation in acute or
chronic inflammatory states. In addition, 1,
a putatively selective agonist of TRPA1,
whether a similar influence of it on TRPV1
could occur to TRPA1 or whether some
objective correlations exist between these
actions still remains to be further
researched in the future study.
3. Experimental
3.1 Materials
Cinnamaldehyde (.99%) was extracted
from Guizhi-Tang. CPT was purchased
from the National Institute for the Control
of Pharmaceutical and Biological Products
(Beijing, China). Laminin, poly-L-lysine,
nerve growth factor (NGF), RR, menthol
($99%), and capsaicin ($99%) were
purchased from Sigma-Aldrich (St Louis,
MO, USA). An RNA extraction kit,
RNAsafe, Oligo (dT) 15, dNTP, and
SYBR green were obtained from Tiangen
Biotech Company (Beijing, China). Super-
script IIIw reverse transcriptase was
purchased from Invitrogen (Carlsbad,
CA, USA). Primers were designed and
synthesized by Shanghai Yingjun Invitro-
gen, Inc. (Shanghai, China). Fluo-4-AM
and Pluronic F-127 were purchased from
Molecular Probes, Inc. (Eugene, OR,
USA). All reagents for cell culture were
of tissue culture grade, and for RNA
extraction, reagents were of molecular
biology grade. All other materials pur-
chased from Sigma-Aldrich were of
analytical grade unless otherwise
indicated.
3.2 Primary cultures of DRG cells
Routine cultures of rat DRG were obtained
from newborn Sprague–Dawley (SD) rats
bred on the campus of Peking Union
Medical College. All protocols were
approved by the Animal Care and Use
Committee of Peking University Health
Science Center, and we followed the
Guidelines of Animal Use and Protection
adopted from the National Institutes of
Health Guide for the Care and Use of
Laboratory Animals (NIH Publications No.
80-23) revised in 1996. All possible efforts
were made to minimize unnecessary suffer-
ing of animals. Briefly, newborn SD rats
were killed by decapitation and submerged
in 95% ethanol for approximately 2min.
DRG were aseptically removed and



































meticulously cleaned of rootlets and con-
nective tissue. The tissue was disaggregated
by incubating in L15 nutrient mixture (pH
corrected to 7.4) containing 0.1% collagen-
ase for 15min at 378C with light trituration
every 5min, and then transferred to 0.25%
trypsin for 30min at 378C with the same
procedures. Following digestion, horse
serum was added to 10% and the cell
suspension centrifuged at low speed for
8min. The cell pellet was resuspended in
neurobasal medium consisting 1% fetal
bovine serum, 1% B-27, 10ng/ml NGF,
2500mg/ml glucose, and 2 g/l NaHCO3.
Cells were seeded onto surfaces precoated
with poly-L-lysine (50 g/ml 70,000–
150,000 Da) and laminin (10 mg/ml).
Cultures were incubated at 378C in a
humidified atmosphere of 5% CO2/95%
air; the medium was replaced routinely
every 2 days. CPT dissolved in DMSO
(10mM stock) was included on day 3 of the
cultures to afinal concentration of20mMfor
a total period of 48 h.
3.3 Treatment of primary cultures of
DRG neurons
The primary DRG neurons were cultured
into six-well cell culture plates or cover-
slips specifically for confocal microscopy.
After the non-neuronal cells were elimi-
nated using CPT, the medium was then
replaced by a serum- and NGF-free culture
medium and recultured for another 24 h
prior to stimulation of experimental
temperature conditions and/or cinnamal-
dehyde of various doses. For the assay of
real-time PCR and confocal experiments,
the cells were incubated with various
concentrations of cinnamaldehyde for 12 h
at 37 or 398C in a humidified atmosphere
of 5% CO2/95% air.
3.4 RNA isolation and reverse
transcription
Total RNA from different samples was
extracted with the RNA extract kit
according to the manufacturer’s protocol.
To avoid DNA contamination, RNA was
treated with the RNase-Free DNase set
(Qiangen, Hilden, Germany). The concen-
tration of RNA was measured spectro-
photometrically and samples were stored
at 2208C until use. The first-strand cDNA
was prepared from 1mg of total RNA with
random hexanucleotide primers using
Superscript IIIw reverse transcriptase.
Reverse transcription was performed at
428C for 30min followed by inactivation
at 948C for 5min. The resulting cDNA was
further used as a template for PCR
amplification immediately or stored at
2208C until use.
3.5 Quantitative real-time PCR
For PCR amplifications, the following
primer pairs were used: rat TRPV1,
forward primer 50-AGT AAC TGC CAG
GAG CTG GA-30 (position 450–469 in
the sequence of rat TRPV1) and reverse
primer 50-GTG TCA TTC TGC CCA TTG
TG-30 (position 576–595 in the sequence
of rat TRPV1); rat TRPM8, forward
primer 50-TGC AGG AGA ACA ACG
ATC AG-30 (position 3004–3023 in the
sequence of rat TRPM8) and reverse
primer 50-GTA AGC GAA GAC GAC
GAA GG-30 (position 3088–3107 in the
sequence of rat TRPM8); and rat GAPDH
(internal control), forward primer 50-CCT
TCA TTG ACC TCA ACT ACA TG-30
(position 180–202 in the sequence of rat
GAPDH) and reverse primer 50-CTT CTC
CAT GGT GGT GAA GAC-30 (position
371–391 in the sequence of rat GAPDH).
Real-time PCR was performed according
to the protocol of the QIANGEN SYBR
Green PCR Kit in an IQ5-type real-time
PCR meter (Bio-Rad, Hercules, CA, USA)
with GAPDH as the endogenous control.
Each amplification program consisted of:
one cycle of 948C for 5min, followed by
50 cycles of 948C at 30 s, 558C for 30 s,
and 728C for 30 s. Melting curves were
generated after the last extension step to



































verify the specificity and identity of PCR
products. Each sample was tested in
triplicate. Relative gene expression was
calculated using the comparative threshold
cycle (22DDCT) method.
3.6 Ca21 imaging experiments on DRG
neurons
DRG neurons were dissociated from
neonate SD rats and plated on coverslips
precoated with poly-D-lysine and laminin
as described above. Ca2þ imaging exper-
iments were performed on neurons the
second day in culture after the purification
processing. The neurons were maintained
in normal bath solution. The normal bath
solution contains HEPES-buffered (pH
7.4) Hanks’ balanced salt solution sup-
plemented with 0.01% bovine serum
albumin, 0.8mM MgCl2, 1.25mM CaCl2,
1mM pyruvate, and 1mM ascorbic acid.
To load the Ca2þ indicator Fluo-4, the
DRG neurons on coverslips were incu-
bated with 5mM Fluo-4-AM in 0.01%
pluronic acid (Molecular Probes) for
30min at 378C. After dye loading, the
cells were washed three times with normal
bath solution and put in a closed chamber
on a microscope stage (Olympus-CK).
Fluo-4 fluorescence in the cells was
detected with a Peltier-cooled charge-
coupled device camera (Penta MAX-III
System; Roper Scientific, Trenton, NJ,
USA) under a 20£ objective. Excitation
and emission were achieved by a fluore-
scence filter set at 488 and 510 nm,
respectively. Images were taken at one
frame per 5 s and digitized using WinView
software (Roper Scientific). The increased
amplitude of intracellular Ca2þ induced by
capsaicin or menthol was tested by bath
application of 5mM capsaicin and 100mM
menthol, respectively. Unless otherwise
indicated, capsaicin or menthol was
applied a new dish in each test and in
each experiment, and cells were exposed
to capsaicin or menthol only once.
For Ca2þ imaging data analysis, relative
fluorescence intensity DF/F0 was used,
and neurons with DF/F0 values of $0.2
(i.e. equal or above 20% of increase) were
assigned as responsive cells [24].
3.7 Statistical analysis
Data are presented as mean ^ SD. Each
type of experiment was performed on the
number of cells indicated (n) in at least
three animals. Data were compared using
Student’s t-tests or one-way ANOVAs
with secondary comparisons made by
using a Student–Newman–Keuls test.
A p-value ,0.05 was considered statisti-
cally significant, unless otherwise
indicated.
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